<DOC>
	<DOC>NCT01034774</DOC>
	<brief_summary>Multiple center, double-blind, randomized, placebo-controlled study to see if it is safe to give ACHN-490 Injection for 5 consecutive days, to measure plasma pharmacokinetics, and to determine lung penetration of ACHN-490 (measured in ELF-epithelial lining fluid)after a single dose of ACHN-490 Injection in healthy volunteers.</brief_summary>
	<brief_title>Phase 1 Study to Determine Safety, Blood PK and Lung Penetration</brief_title>
	<detailed_description />
	<criteria>Men or Women Within normal weight limits In good health with normal routine laboratory results Willing to not use media players (such as MP3 players) or devices with ear pieces and avoid exposure to loud noises No ongoing medical conditions such as heart disease, high blood pressure, asthma, diabetes, seizures, or kidney problems No problems with hearing or balance No previous injury or surgery to the ears No family history of hearing loss before the age of 65 Not taking any medications other than birth control medication Smokers or use of tobacco products Recent blood donors No excessive alcohol intake or illegal substances No allergy to aminoglycosides (a type of antibiotic)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>Human volunteers</keyword>
</DOC>